MannKind Corporation to Present at Upcoming Conferences

MannKind Corporation to Present at Upcoming Conferences

VALENCIA, Calif., Feb. 19, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation
(Nasdaq:MNKD) focused on discovering, developing and commercializing
treatments for diabetes, announced today that it will present at upcoming
conferences.

  *The RBC Capital Markets 2014 Global Healthcare Conference on February 25,
    2014 at 11:30 AM (ET) at The New York Palace in New York, New York.
    
  *Cowen and Company 34^th Annual Health Care Conference on March 3, 2014 at
    3:30 PM (ET) at the Boston Marriott Copley in Boston, Massachusetts.

Interested parties can access a link to the live webcast of the presentations
from the News & Events section of the Company's website at
http://www.mannkindcorp.com.

About MannKind Corporation

MannKind Corporation (Nasdaq:MNKD) focuses on the discovery, development and
commercialization of therapeutic products for patients with diseases such as
diabetes. Its lead product candidate, AFREZZA®, has completed Phase 3 clinical
trials.

MannKind maintains a website at http://www.mannkindcorp.com to which MannKind
regularly posts copies of its press releases as well as additional information
about MannKind. Interested persons can subscribe on the MannKind website to
e-mail alerts that are sent automatically when MannKind issues press releases,
files its reports with the Securities and Exchange Commission or posts certain
other information to the website.

CONTACT: Company Contact:
         Matthew J. Pfeffer
         Chief Financial Officer
         661-775-5300
         mpfeffer@mannkindcorp.com

MannKind Corporation Logo
 
Press spacebar to pause and continue. Press esc to stop.